The results suggested that in the RNA sequencing data obtained from bone marrow endothelial progenitor cells (GSE197907, Additional file 1: Fig. S1a) or bone marrow immune cells (GSE154109, Additional file 1: Fig. S1b) isolated from AML patients or healthy donors, the average TFRC expression in AML patient cells was significantly higher than that in healthy donor cells. This evidence concerns the gene TFRC and acute myeloid leukemia.